Annual Total Long Term Liabilities
$0.00
-$158.64 M-100.00%
December 31, 2023
Summary
- As of February 12, 2025, MLYS annual total long term liabilities is $0.00, with the most recent change of -$158.64 million (-100.00%) on December 31, 2023.
- During the last 3 years, MLYS annual total long term liabilities has risen by $0.00 (0.00%).
- MLYS annual total long term liabilities is now -100.00% below its all-time high of $158.64 million, reached on December 31, 2022.
Performance
MLYS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 12, 2025, MLYS quarterly total long term liabilities is $0.00, unchanged on September 30, 2024.
- Over the past year, MLYS quarterly long term liabilities has stayed the same.
- MLYS quarterly long term liabilities is now -100.00% below its all-time high of $158.64 million, reached on September 30, 2022.
Performance
MLYS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
MLYS Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | 0.0% |
| 3 y3 years | 0.0% | 0.0% |
| 5 y5 years | 0.0% | 0.0% |
MLYS Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low |
Mineralys Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $0.00 | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $0.00(-100.0%) |
| Dec 2022 | $158.64 M(+447.1%) | $158.64 M(0.0%) |
| Sep 2022 | - | $158.64 M(+447.1%) |
| Dec 2021 | $29.00 M(>+9900.0%) | - |
| Dec 2021 | - | $29.00 M |
| Dec 2020 | $0.00 | - |
FAQ
- What is Mineralys Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual total long term liabilities year-on-year change?
- What is Mineralys Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly long term liabilities year-on-year change?
What is Mineralys Therapeutics annual total long term liabilities?
The current annual total long term liabilities of MLYS is $0.00
What is the all time high annual total long term liabilities for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual total long term liabilities is $158.64 M
What is Mineralys Therapeutics annual total long term liabilities year-on-year change?
Over the past year, MLYS annual total long term liabilities has changed by -$158.64 M (-100.00%)
What is Mineralys Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of MLYS is $0.00
What is the all time high quarterly long term liabilities for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly total long term liabilities is $158.64 M
What is Mineralys Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, MLYS quarterly total long term liabilities has changed by $0.00 (0.00%)